AI Uncovers Bufalin as Estrogen Receptor Degrader
In a groundbreaking convergence of artificial intelligence and molecular pharmacology, researchers have unveiled Bufalin as a novel molecular glue degrader ...
In a groundbreaking convergence of artificial intelligence and molecular pharmacology, researchers have unveiled Bufalin as a novel molecular glue degrader ...
In a groundbreaking study poised to shift the paradigm in gastric cancer therapeutics, researchers have unveiled a novel strategy to ...
Scientists have made a groundbreaking advancement in cancer research, unveiling a novel tool designed to predict how bowel cancer cells ...
In a groundbreaking development that could reshape the landscape of cancer immunotherapy, researchers from Singapore’s ASTAR Institute of Molecular and ...
In the relentless pursuit of innovative therapies addressing the formidable challenge of drug resistance, a transformative strategy has emerged from ...
In the complex landscape of cancer treatment, drug resistance remains a formidable challenge, especially in melanoma, a type of skin ...
A recent study from the VCU Massey Comprehensive Cancer Center has generated significant excitement in the fight against lung cancer, ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine